139 related articles for article (PubMed ID: 23842702)
1. Attenuation of spontaneous thrombolytic activity measured by the global thrombosis test in male habitual smokers.
Suehiro A; Wakabayashi I; Yamashita T; Yamamoto J
J Thromb Thrombolysis; 2014 May; 37(4):414-8. PubMed ID: 23842702
[TBL] [Abstract][Full Text] [Related]
2. Impaired spontaneous thrombolytic activity in elderly and in habitual smokers, as measured by a new global thrombosis test.
Ikarugi H; Yamashita T; Aoki R; Ishii H; Kanki K; Yamamoto J
Blood Coagul Fibrinolysis; 2003 Dec; 14(8):781-4. PubMed ID: 14614361
[TBL] [Abstract][Full Text] [Related]
3. Marked impairment of protease-activated receptor type 1-mediated vasodilation and fibrinolysis in cigarette smokers: smoking, thrombin, and vascular responses in vivo.
Lang NN; Gudmundsdóttir IJ; Boon NA; Ludlam CA; Fox KA; Newby DE
J Am Coll Cardiol; 2008 Jul; 52(1):33-9. PubMed ID: 18582632
[TBL] [Abstract][Full Text] [Related]
4. Impaired endogenous thrombolysis in acute coronary syndrome patients predicts cardiovascular death and nonfatal myocardial infarction.
Saraf S; Christopoulos C; Salha IB; Stott DJ; Gorog DA
J Am Coll Cardiol; 2010 May; 55(19):2107-15. PubMed ID: 20447533
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effect of cigarette smoking cessation on fibrin clot properties.
Stępień E; Miszalski-Jamka T; Kapusta P; Tylko G; Pasowicz M
J Thromb Thrombolysis; 2011 Aug; 32(2):177-82. PubMed ID: 21538069
[TBL] [Abstract][Full Text] [Related]
6. Smoking, haemostatic factors, and cardiovascular risk.
Leone A
Curr Pharm Des; 2007; 13(16):1661-7. PubMed ID: 17584096
[TBL] [Abstract][Full Text] [Related]
7. Apixaban enhances endogenous fibrinolysis in patients with atrial fibrillation.
Spinthakis N; Gue Y; Farag M; Srinivasan M; Wellsted D; Arachchillage DRJ; Lip GYH; Gorog DA
Europace; 2019 Sep; 21(9):1297-1306. PubMed ID: 31505618
[TBL] [Abstract][Full Text] [Related]
8. Lysis Timer: a new sensitive tool to diagnose hyperfibrinolysis in liver transplantation.
Roullet S; Labrouche S; Mouton C; Quinart A; Nouette-Gaulain K; Laurent C; Freyburger G
J Clin Pathol; 2019 Jan; 72(1):58-65. PubMed ID: 30282673
[TBL] [Abstract][Full Text] [Related]
9. Global Thrombosis Test (GTT) can detect major determinants of haemostasis including platelet reactivity, endogenous fibrinolytic and thrombin generating potential.
Yamamoto J; Inoue N; Otsui K; Ishii H; Gorog DA
Thromb Res; 2014 May; 133(5):919-26. PubMed ID: 24613697
[TBL] [Abstract][Full Text] [Related]
10. Impaired spontaneous thrombolytic activity measured by global thrombosis test in males with metabolic syndrome.
Suehiro A; Wakabayashi I; Uchida K; Yamashita T; Yamamoto J
Thromb Res; 2012 Apr; 129(4):499-501. PubMed ID: 21752433
[TBL] [Abstract][Full Text] [Related]
11. Blood clot contraction differentially modulates internal and external fibrinolysis.
Tutwiler V; Peshkova AD; Le Minh G; Zaitsev S; Litvinov RI; Cines DB; Weisel JW
J Thromb Haemost; 2019 Feb; 17(2):361-370. PubMed ID: 30582674
[TBL] [Abstract][Full Text] [Related]
12. MASP-1 of the complement system alters fibrinolytic behaviour of blood clots.
Jenny L; Noser D; Larsen JB; Dobó J; Gál P; Pál G; Schroeder V
Mol Immunol; 2019 Oct; 114():1-9. PubMed ID: 31325724
[TBL] [Abstract][Full Text] [Related]
13. A new assay for global fibrinolysis capacity (GFC): Investigating a critical system regulating hemostasis and thrombosis and other extravascular functions.
Amiral J; Laroche M; Seghatchian J
Transfus Apher Sci; 2018 Feb; 57(1):118-126. PubMed ID: 29525568
[TBL] [Abstract][Full Text] [Related]
14. Smoking and fibrinolysis.
Janzon L; Nilsson IM
Circulation; 1975 Jun; 51(6):1120-3. PubMed ID: 1132101
[TBL] [Abstract][Full Text] [Related]
15. Thrombin-activatable fibrinolysis inhibitor in hypothyroidism and hyperthyroxinaemia.
Verkleij CJ; Stuijver DJ; van Zaane B; Squizzato A; Brandjes DP; Büller HR; Meijers JC; Gerdes VE
Thromb Haemost; 2013 Feb; 109(2):214-20. PubMed ID: 23197299
[TBL] [Abstract][Full Text] [Related]
16. Fibrin clot formation and fibrinolysis in patients with a history of coronary stent thrombosis.
Godschalk TC; Konings J; Govers-Riemslag JW; Ten Berg JM; Hackeng CM; Ten Cate H
Thromb Res; 2016 Jul; 143():58-62. PubMed ID: 27191854
[TBL] [Abstract][Full Text] [Related]
17. Altered plasma fibrin clot properties in hypertensive patients with obstructive sleep apnoea are improved by continuous positive airway pressure treatment.
Jóźwik-Plebanek K; Prejbisz A; Wypasek E; Pręgowska-Chwała B; Hanus K; Kaszuba AM; Januszewicz M; Bieleń P; Kabat M; Kruk M; Dobrowolski P; Klisiewicz A; Śliwiński P; Januszewicz A; Undas A
J Hypertens; 2017 May; 35(5):1035-1043. PubMed ID: 28141659
[TBL] [Abstract][Full Text] [Related]
18. Catheter ablation for AF improves global thrombotic profile and enhances fibrinolysis.
Niespialowska-Steuden M; Markides V; Farag M; Jones D; Hussain W; Wong T; Gorog DA
J Thromb Thrombolysis; 2017 Nov; 44(4):413-426. PubMed ID: 28921408
[TBL] [Abstract][Full Text] [Related]
19. Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction.
Newby DE; Wright RA; Labinjoh C; Ludlam CA; Fox KA; Boon NA; Webb DJ
Circulation; 1999 Mar; 99(11):1411-5. PubMed ID: 10086962
[TBL] [Abstract][Full Text] [Related]
20. Acute cigarette smoke exposure reduces clot lysis--association between altered fibrin architecture and the response to t-PA.
Barua RS; Sy F; Srikanth S; Huang G; Javed U; Buhari C; Margosan D; Aftab W; Ambrose JA
Thromb Res; 2010 Nov; 126(5):426-30. PubMed ID: 20813396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
